Ferguson Km, B. M.; Berger, M. B.; Mendrola, J. M.; Cho, H. S.; Leahy, D. J.; Lemmon, M. A. (2003). „EGF activates its receptor by removing interactions that autoinhibit ectodomain dimerization”. Molecular Cell11 (2): 507–517. DOI:10.1016/S1097-2765(03)00047-9. PMID12620237.edit
Ikeda, K; Nomori, H; Mori, T; Sasaki, J; Kobayashi, T (2008). „Novel germline mutation: EGFR V843I in patient with multiple lung adenocarcinomas and family members with lung cancer”. The Annals of Thoracic Surgery85 (4): 1430-2. DOI:10.1016/j.athoracsur.2007.10.012. PMID18355544.edit
Bonaccorsi L, Carloni Vinicio, Muratori Monica, Formigli Lucia, Zecchi Sandra, Forti Gianni, Baldi Elisabetta (Oct 2004). „EGF receptor (EGFR) signaling promoting invasion is disrupted in androgen-sensitive prostate cancer cells by an interaction between EGFR and androgen receptor (AR)”. Int. J. Cancer112 (1): 78–86. DOI:10.1002/ijc.20362. PMID15305378.
Bonaccorsi L, Muratori M, Carloni V, Marchiani S, Formigli L, Forti G, Baldi E (Aug 2004). „The androgen receptor associates with the epidermal growth factor receptor in androgen-sensitive prostate cancer cells”. Steroids69 (8-9): 549–52. DOI:10.1016/j.steroids.2004.05.011. PMID15288768.
Kim S-W, Hayashi Masaaki, Lo Jeng-Fan, Yang Young, Yoo Jin-San, Lee Jiing-Dwan (Jan 2003). „ADP-ribosylation factor 4 small GTPase mediates epidermal growth factor receptor-dependent phospholipase D2 activation”. J. Biol. Chem.278 (4): 2661–8. DOI:10.1074/jbc.M205819200. PMID12446727.
Couet J, Sargiacomo M, Lisanti M P (Nov 1997). „Interaction of a receptor tyrosine kinase, EGF-R, with caveolins. Caveolin binding negatively regulates tyrosine and serine/threonine kinase activities”. J. Biol. Chem.272 (48): 30429–38. DOI:10.1074/jbc.272.48.30429. PMID9374534.
Tvorogov D, Carpenter Graham (Jul 2002). „EGF-dependent association of phospholipase C-gamma1 with c-Cbl”. Exp. Cell Res.277 (1): 86–94. DOI:10.1006/excr.2002.5545. PMID12061819.
Ettenberg SA, Keane M M, Nau M M, Frankel M, Wang L M, Pierce J H, Lipkowitz S (Mar 1999). „cbl-b inhibits epidermal growth factor receptor signaling”. Oncogene18 (10): 1855–66. DOI:10.1038/sj.onc.1202499. PMID10086340.
Kim M, Tezuka T, Suziki Y, Sugano S, Hirai M, Yamamoto T (Oct 1999). „Molecular cloning and characterization of a novel cbl-family gene, cbl-c”. Gene239 (1): 145–54. DOI:10.1016/S0378-1119(99)00356-X. PMID10571044.
Keane MM, Ettenberg S A, Nau M M, Banerjee P, Cuello M, Penninger J, Lipkowitz S (Jun 1999). „cbl-3: a new mammalian cbl family protein”. Oncogene18 (22): 3365–75. DOI:10.1038/sj.onc.1202753. PMID10362357.
Wang Z, Wang Meifang, Lazo John S, Carr Brian I (May 2002). „Identification of epidermal growth factor receptor as a target of Cdc25A protein phosphatase”. J. Biol. Chem.277 (22): 19470–5. DOI:10.1074/jbc.M201097200. PMID11912208.
Hashimoto Y, Katayama H, Kiyokawa E, Ota S, Kurata T, Gotoh N, Otsuka N, Shibata M, Matsuda M (Jul 1998). „Phosphorylation of CrkII adaptor protein at tyrosine 221 by epidermal growth factor receptor”. J. Biol. Chem.273 (27): 17186–91. DOI:10.1074/jbc.273.27.17186. PMID9642287.
Hazan RB, Norton L (Apr 1998). „The epidermal growth factor receptor modulates the interaction of E-cadherin with the actin cytoskeleton”. J. Biol. Chem.273 (15): 9078–84. DOI:10.1074/jbc.273.15.9078. PMID9535896.
Schroeder JA, Adriance Melissa C, McConnell Elizabeth J, Thompson Melissa C, Pockaj Barbara, Gendler Sandra J (Jun 2002). „ErbB-beta-catenin complexes are associated with human infiltrating ductal breast and murine mammary tumor virus (MMTV)-Wnt-1 and MMTV-c-Neu transgenic carcinomas”. J. Biol. Chem.277 (25): 22692–8. DOI:10.1074/jbc.M201975200. PMID11950845.
Takahashi K, Suzuki K, Tsukatani Y (Jul 1997). „Induction of tyrosine phosphorylation and association of beta-catenin with EGF receptor upon tryptic digestion of quiescent cells at confluence”. Oncogene15 (1): 71–8. DOI:10.1038/sj.onc.1201160. PMID9233779.
Santra M, Reed Charles C, Iozzo Renato V (Sep 2002). „Decorin binds to a narrow region of the epidermal growth factor (EGF) receptor, partially overlapping but distinct from the EGF-binding epitope”. J. Biol. Chem.277 (38): 35671–81. DOI:10.1074/jbc.M205317200. PMID12105206.
Iozzo RV, Moscatello D K, McQuillan D J, Eichstetter I (Feb 1999). „Decorin is a biological ligand for the epidermal growth factor receptor”. J. Biol. Chem.274 (8): 4489–92. DOI:10.1074/jbc.274.8.4489. PMID9988678.
Wong L, Deb T B, Thompson S A, Wells A, Johnson G R (Mar 1999). „A differential requirement for the COOH-terminal region of the epidermal growth factor (EGF) receptor in amphiregulin and EGF mitogenic signaling”. J. Biol. Chem.274 (13): 8900–9. DOI:10.1074/jbc.274.13.8900. PMID10085134.
Stortelers C, Souriau Christelle, van Liempt Ellis, van de Poll Monique L M, van Zoelen Everardus J J (Jul 2002). „Role of the N-terminus of epidermal growth factor in ErbB-2/ErbB-3 binding studied by phage display”. Biochemistry41 (27): 8732–41. DOI:10.1021/bi025878c. PMID12093292.
Daly RJ, Sanderson G M, Janes P W, Sutherland R L (May 1996). „Cloning and characterization of GRB14, a novel member of the GRB7 gene family”. J. Biol. Chem.271 (21): 12502–10. DOI:10.1074/jbc.271.21.12502. PMID8647858.
Braverman LE, Quilliam L A (Feb 1999). „Identification of Grb4/Nckbeta, a src homology 2 and 3 domain-containing adapter protein having similar binding and biological properties to Nck”. J. Biol. Chem.274 (9): 5542–9. DOI:10.1074/jbc.274.9.5542. PMID10026169.
Oneyama C, Nakano Hirofumi, Sharma Sreenath V (Mar 2002). „UCS15A, a novel small molecule, SH3 domain-mediated protein-protein interaction blocking drug”. Oncogene21 (13): 2037–50. DOI:10.1038/sj.onc.1205271. PMID11960376.
Tortora G, Damiano V, Bianco C, Baldassarre G, Bianco A R, Lanfrancone L, Pelicci P G, Ciardiello F (Feb 1997). „The RIalpha subunit of protein kinase A (PKA) binds to Grb2 and allows PKA interaction with the activated EGF-receptor”. Oncogene14 (8): 923–8. DOI:10.1038/sj.onc.1200906. PMID9050991.
Lowenstein EJ, Daly R J, Batzer A G, Li W, Margolis B, Lammers R, Ullrich A, Skolnik E Y, Bar-Sagi D, Schlessinger J (Aug 1992). „The SH2 and SH3 domain-containing protein GRB2 links receptor tyrosine kinases to ras signaling”. Cell70 (3): 431–42. DOI:10.1016/0092-8674(92)90167-B. PMID1322798.
Olayioye MA, Beuvink I, Horsch K, Daly J M, Hynes N E (Jun 1999). „ErbB receptor-induced activation of stat transcription factors is mediated by Src tyrosine kinases”. J. Biol. Chem.274 (24): 17209–18. DOI:10.1074/jbc.274.24.17209. PMID10358079.
Schroeder JA, Thompson M C, Gardner M M, Gendler S J (Apr 2001). „Transgenic MUC1 interacts with epidermal growth factor receptor and correlates with mitogen-activated protein kinase activation in the mouse mammary gland”. J. Biol. Chem.276 (16): 13057–64. DOI:10.1074/jbc.M011248200. PMID11278868.
Li Y, Ren J, Yu W, Li Q, Kuwahara H, Yin L, Carraway K L, Kufe D (Sep 2001). „The epidermal growth factor receptor regulates interaction of the human DF3/MUC1 carcinoma antigen with c-Src and beta-catenin”. J. Biol. Chem.276 (38): 35239–42. DOI:10.1074/jbc.C100359200. PMID11483589.
Tang J, Feng G S, Li W (Oct 1997). „Induced direct binding of the adapter protein Nck to the GTPase-activating protein-associated protein p62 by epidermal growth factor”. Oncogene15 (15): 1823–32. DOI:10.1038/sj.onc.1201351. PMID9362449.
Chen M, She H, Davis E M, Spicer C M, Kim L, Ren R, Le Beau M M, Li W (Sep 1998). „Identification of Nck family genes, chromosomal localization, expression, and signaling specificity”. J. Biol. Chem.273 (39): 25171–8. DOI:10.1074/jbc.273.39.25171. PMID9737977.
Gauthier ML, Torretto Cheryl, Ly John, Francescutti Valerie, O'Day Danton H (Aug 2003). „Protein kinase Calpha negatively regulates cell spreading and motility in MDA-MB-231 human breast cancer cells downstream of epidermal growth factor receptor”. Biochem. Biophys. Res. Commun.307 (4): 839–46. DOI:10.1016/S0006-291X(03)01273-7. PMID12878187.
Bedrin MS, Abolafia C M, Thompson J F (Jul 1997). „Cytoskeletal association of epidermal growth factor receptor and associated signaling proteins is regulated by cell density in IEC-6 intestinal cells”. J. Cell. Physiol.172 (1): 126–36. DOI:10.1002/(SICI)1097-4652(199707)172:1<126::AID-JCP14>3.0.CO;2-A. PMID9207933.
Sun J, Nanjundan Meera, Pike Linda J, Wiedmer Therese, Sims Peter J (May 2002). „Plasma membrane phospholipid scramblase 1 is enriched in lipid rafts and interacts with the epidermal growth factor receptor”. Biochemistry41 (20): 6338–45. DOI:10.1021/bi025610l. PMID12009895.
Sarmiento M, Puius Y A, Vetter S W, Keng Y F, Wu L, Zhao Y, Lawrence D S, Almo S C, Zhang Z Y (Jul 2000). „Structural basis of plasticity in protein tyrosine phosphatase 1B substrate recognition”. Biochemistry39 (28): 8171–9. DOI:10.1021/bi000319w. PMID10889023.
Zhang ZY, Walsh A B, Wu L, McNamara D J, Dobrusin E M, Miller W T (Mar 1996). „Determinants of substrate recognition in the protein-tyrosine phosphatase, PTP1”. J. Biol. Chem.271 (10): 5386–92. DOI:10.1074/jbc.271.10.5386. PMID8621392.
Tomic S, Greiser U, Lammers R, Kharitonenkov A, Imyanitov E, Ullrich A, Böhmer F D (Sep 1995). „Association of SH2 domain protein tyrosine phosphatases with the epidermal growth factor receptor in human tumor cells. Phosphatidic acid activates receptor dephosphorylation by PTP1C”. J. Biol. Chem.270 (36): 21277–84. DOI:10.1074/jbc.270.36.21277. PMID7673163.
Keilhack H, Tenev T, Nyakatura E, Godovac-Zimmermann J, Nielsen L, Seedorf K, Böhmer F D (Sep 1998). „Phosphotyrosine 1173 mediates binding of the protein-tyrosine phosphatase SHP-1 to the epidermal growth factor receptor and attenuation of receptor signaling”. J. Biol. Chem.273 (38): 24839–46. DOI:10.1074/jbc.273.38.24839. PMID9733788.
Lu Y, Brush J, Stewart T A (Apr 1999). „NSP1 defines a novel family of adaptor proteins linking integrin and tyrosine kinase receptors to the c-Jun N-terminal kinase/stress-activated protein kinase signaling pathway”. J. Biol. Chem.274 (15): 10047–52. DOI:10.1074/jbc.274.15.10047. PMID10187783.
Soubeyran P, Kowanetz Katarzyna, Szymkiewicz Iwona, Langdon Wallace Y, Dikic Ivan (Mar 2002). „Cbl-CIN85-endophilin complex mediates ligand-induced downregulation of EGF receptors”. Nature416 (6877): 183–7. DOI:10.1038/416183a. PMID11894095.
Szymkiewicz I, Kowanetz Katarzyna, Soubeyran Philippe, Dinarina Ana, Lipkowitz Stanley, Dikic Ivan (Oct 2002). „CIN85 participates in Cbl-b-mediated down-regulation of receptor tyrosine kinases”. J. Biol. Chem.277 (42): 39666–72. DOI:10.1074/jbc.M205535200. PMID12177062.
Sakaguchi K, Okabayashi Y, Kido Y, Kimura S, Matsumura Y, Inushima K, Kasuga M (Apr 1998). „Shc phosphotyrosine-binding domain dominantly interacts with epidermal growth factor receptors and mediates Ras activation in intact cells”. Mol. Endocrinol.12 (4): 536–43. DOI:10.1210/me.12.4.536. PMID9544989.
Keely SJ, Calandrella S O, Barrett K E (Apr 2000). „Carbachol-stimulated transactivation of epidermal growth factor receptor and mitogen-activated protein kinase in T(84) cells is mediated by intracellular ca(2+), PYK-2, and p60(src)”. J. Biol. Chem.275 (17): 12619–25. DOI:10.1074/jbc.275.17.12619. PMID10777553.
Sato K, Kimoto M, Kakumoto M, Horiuchi D, Iwasaki T, Tokmakov A A, Fukami Y (Sep 2000). „Adaptor protein Shc undergoes translocation and mediates up-regulation of the tyrosine kinase c-Src in EGF-stimulated A431 cells”. Genes Cells5 (9): 749–64. DOI:10.1046/j.1365-2443.2000.00358.x. PMID10971656.
Xia L, Wang Lijuan, Chung Alicia S, Ivanov Stanimir S, Ling Mike Y, Dragoi Ana M, Platt Adam, Gilmer Tona M, Fu Xin-Yuan, Chin Y Eugene (Aug 2002). „Identification of both positive and negative domains within the epidermal growth factor receptor COOH-terminal region for signal transducer and activator of transcription (STAT) activation”. J. Biol. Chem.277 (34): 30716–23. DOI:10.1074/jbc.M202823200. PMID12070153.
Sehat B, Andersson Sandra, Girnita Leonard, Larsson Olle (Jul 2008). „Identification of c-Cbl as a new ligase for insulin-like growth factor-I receptor with distinct roles from Mdm2 in receptor ubiquitination and endocytosis”. Cancer Res.68 (14): 5669–77. DOI:10.1158/0008-5472.CAN-07-6364. PMID18632619.
nih.gov
ncbi.nlm.nih.gov
Ferguson Km, B. M.; Berger, M. B.; Mendrola, J. M.; Cho, H. S.; Leahy, D. J.; Lemmon, M. A. (2003). „EGF activates its receptor by removing interactions that autoinhibit ectodomain dimerization”. Molecular Cell11 (2): 507–517. DOI:10.1016/S1097-2765(03)00047-9. PMID12620237.edit
Ikeda, K; Nomori, H; Mori, T; Sasaki, J; Kobayashi, T (2008). „Novel germline mutation: EGFR V843I in patient with multiple lung adenocarcinomas and family members with lung cancer”. The Annals of Thoracic Surgery85 (4): 1430-2. DOI:10.1016/j.athoracsur.2007.10.012. PMID18355544.edit
Bonaccorsi L, Carloni Vinicio, Muratori Monica, Formigli Lucia, Zecchi Sandra, Forti Gianni, Baldi Elisabetta (Oct 2004). „EGF receptor (EGFR) signaling promoting invasion is disrupted in androgen-sensitive prostate cancer cells by an interaction between EGFR and androgen receptor (AR)”. Int. J. Cancer112 (1): 78–86. DOI:10.1002/ijc.20362. PMID15305378.
Bonaccorsi L, Muratori M, Carloni V, Marchiani S, Formigli L, Forti G, Baldi E (Aug 2004). „The androgen receptor associates with the epidermal growth factor receptor in androgen-sensitive prostate cancer cells”. Steroids69 (8-9): 549–52. DOI:10.1016/j.steroids.2004.05.011. PMID15288768.
Kim S-W, Hayashi Masaaki, Lo Jeng-Fan, Yang Young, Yoo Jin-San, Lee Jiing-Dwan (Jan 2003). „ADP-ribosylation factor 4 small GTPase mediates epidermal growth factor receptor-dependent phospholipase D2 activation”. J. Biol. Chem.278 (4): 2661–8. DOI:10.1074/jbc.M205819200. PMID12446727.
Couet J, Sargiacomo M, Lisanti M P (Nov 1997). „Interaction of a receptor tyrosine kinase, EGF-R, with caveolins. Caveolin binding negatively regulates tyrosine and serine/threonine kinase activities”. J. Biol. Chem.272 (48): 30429–38. DOI:10.1074/jbc.272.48.30429. PMID9374534.
Tvorogov D, Carpenter Graham (Jul 2002). „EGF-dependent association of phospholipase C-gamma1 with c-Cbl”. Exp. Cell Res.277 (1): 86–94. DOI:10.1006/excr.2002.5545. PMID12061819.
Ettenberg SA, Keane M M, Nau M M, Frankel M, Wang L M, Pierce J H, Lipkowitz S (Mar 1999). „cbl-b inhibits epidermal growth factor receptor signaling”. Oncogene18 (10): 1855–66. DOI:10.1038/sj.onc.1202499. PMID10086340.
Kim M, Tezuka T, Suziki Y, Sugano S, Hirai M, Yamamoto T (Oct 1999). „Molecular cloning and characterization of a novel cbl-family gene, cbl-c”. Gene239 (1): 145–54. DOI:10.1016/S0378-1119(99)00356-X. PMID10571044.
Keane MM, Ettenberg S A, Nau M M, Banerjee P, Cuello M, Penninger J, Lipkowitz S (Jun 1999). „cbl-3: a new mammalian cbl family protein”. Oncogene18 (22): 3365–75. DOI:10.1038/sj.onc.1202753. PMID10362357.
Wang Z, Wang Meifang, Lazo John S, Carr Brian I (May 2002). „Identification of epidermal growth factor receptor as a target of Cdc25A protein phosphatase”. J. Biol. Chem.277 (22): 19470–5. DOI:10.1074/jbc.M201097200. PMID11912208.
Hashimoto Y, Katayama H, Kiyokawa E, Ota S, Kurata T, Gotoh N, Otsuka N, Shibata M, Matsuda M (Jul 1998). „Phosphorylation of CrkII adaptor protein at tyrosine 221 by epidermal growth factor receptor”. J. Biol. Chem.273 (27): 17186–91. DOI:10.1074/jbc.273.27.17186. PMID9642287.
Hazan RB, Norton L (Apr 1998). „The epidermal growth factor receptor modulates the interaction of E-cadherin with the actin cytoskeleton”. J. Biol. Chem.273 (15): 9078–84. DOI:10.1074/jbc.273.15.9078. PMID9535896.
Schroeder JA, Adriance Melissa C, McConnell Elizabeth J, Thompson Melissa C, Pockaj Barbara, Gendler Sandra J (Jun 2002). „ErbB-beta-catenin complexes are associated with human infiltrating ductal breast and murine mammary tumor virus (MMTV)-Wnt-1 and MMTV-c-Neu transgenic carcinomas”. J. Biol. Chem.277 (25): 22692–8. DOI:10.1074/jbc.M201975200. PMID11950845.
Takahashi K, Suzuki K, Tsukatani Y (Jul 1997). „Induction of tyrosine phosphorylation and association of beta-catenin with EGF receptor upon tryptic digestion of quiescent cells at confluence”. Oncogene15 (1): 71–8. DOI:10.1038/sj.onc.1201160. PMID9233779.
Santra M, Reed Charles C, Iozzo Renato V (Sep 2002). „Decorin binds to a narrow region of the epidermal growth factor (EGF) receptor, partially overlapping but distinct from the EGF-binding epitope”. J. Biol. Chem.277 (38): 35671–81. DOI:10.1074/jbc.M205317200. PMID12105206.
Iozzo RV, Moscatello D K, McQuillan D J, Eichstetter I (Feb 1999). „Decorin is a biological ligand for the epidermal growth factor receptor”. J. Biol. Chem.274 (8): 4489–92. DOI:10.1074/jbc.274.8.4489. PMID9988678.
Wong L, Deb T B, Thompson S A, Wells A, Johnson G R (Mar 1999). „A differential requirement for the COOH-terminal region of the epidermal growth factor (EGF) receptor in amphiregulin and EGF mitogenic signaling”. J. Biol. Chem.274 (13): 8900–9. DOI:10.1074/jbc.274.13.8900. PMID10085134.
Stortelers C, Souriau Christelle, van Liempt Ellis, van de Poll Monique L M, van Zoelen Everardus J J (Jul 2002). „Role of the N-terminus of epidermal growth factor in ErbB-2/ErbB-3 binding studied by phage display”. Biochemistry41 (27): 8732–41. DOI:10.1021/bi025878c. PMID12093292.
Daly RJ, Sanderson G M, Janes P W, Sutherland R L (May 1996). „Cloning and characterization of GRB14, a novel member of the GRB7 gene family”. J. Biol. Chem.271 (21): 12502–10. DOI:10.1074/jbc.271.21.12502. PMID8647858.
Braverman LE, Quilliam L A (Feb 1999). „Identification of Grb4/Nckbeta, a src homology 2 and 3 domain-containing adapter protein having similar binding and biological properties to Nck”. J. Biol. Chem.274 (9): 5542–9. DOI:10.1074/jbc.274.9.5542. PMID10026169.
Oneyama C, Nakano Hirofumi, Sharma Sreenath V (Mar 2002). „UCS15A, a novel small molecule, SH3 domain-mediated protein-protein interaction blocking drug”. Oncogene21 (13): 2037–50. DOI:10.1038/sj.onc.1205271. PMID11960376.
Okutani T, Okabayashi Y, Kido Y, Sugimoto Y, Sakaguchi K, Matuoka K, Takenawa T, Kasuga M (Dec 1994). „Grb2/Ash binds directly to tyrosines 1068 and 1086 and indirectly to tyrosine 1148 of activated human epidermal growth factor receptors in intact cells”. J. Biol. Chem.269 (49): 31310–4. PMID7527043.
Tortora G, Damiano V, Bianco C, Baldassarre G, Bianco A R, Lanfrancone L, Pelicci P G, Ciardiello F (Feb 1997). „The RIalpha subunit of protein kinase A (PKA) binds to Grb2 and allows PKA interaction with the activated EGF-receptor”. Oncogene14 (8): 923–8. DOI:10.1038/sj.onc.1200906. PMID9050991.
Buday L, Egan S E, Rodriguez Viciana P, Cantrell D A, Downward J (Mar 1994). „A complex of Grb2 adaptor protein, Sos exchange factor, and a 36-kDa membrane-bound tyrosine phosphoprotein is implicated in ras activation in T cells”. J. Biol. Chem.269 (12): 9019–23. PMID7510700.
Lowenstein EJ, Daly R J, Batzer A G, Li W, Margolis B, Lammers R, Ullrich A, Skolnik E Y, Bar-Sagi D, Schlessinger J (Aug 1992). „The SH2 and SH3 domain-containing protein GRB2 links receptor tyrosine kinases to ras signaling”. Cell70 (3): 431–42. DOI:10.1016/0092-8674(92)90167-B. PMID1322798.
Olayioye MA, Beuvink I, Horsch K, Daly J M, Hynes N E (Jun 1999). „ErbB receptor-induced activation of stat transcription factors is mediated by Src tyrosine kinases”. J. Biol. Chem.274 (24): 17209–18. DOI:10.1074/jbc.274.24.17209. PMID10358079.
Schroeder JA, Thompson M C, Gardner M M, Gendler S J (Apr 2001). „Transgenic MUC1 interacts with epidermal growth factor receptor and correlates with mitogen-activated protein kinase activation in the mouse mammary gland”. J. Biol. Chem.276 (16): 13057–64. DOI:10.1074/jbc.M011248200. PMID11278868.
Li Y, Ren J, Yu W, Li Q, Kuwahara H, Yin L, Carraway K L, Kufe D (Sep 2001). „The epidermal growth factor receptor regulates interaction of the human DF3/MUC1 carcinoma antigen with c-Src and beta-catenin”. J. Biol. Chem.276 (38): 35239–42. DOI:10.1074/jbc.C100359200. PMID11483589.
Tang J, Feng G S, Li W (Oct 1997). „Induced direct binding of the adapter protein Nck to the GTPase-activating protein-associated protein p62 by epidermal growth factor”. Oncogene15 (15): 1823–32. DOI:10.1038/sj.onc.1201351. PMID9362449.
Chen M, She H, Davis E M, Spicer C M, Kim L, Ren R, Le Beau M M, Li W (Sep 1998). „Identification of Nck family genes, chromosomal localization, expression, and signaling specificity”. J. Biol. Chem.273 (39): 25171–8. DOI:10.1074/jbc.273.39.25171. PMID9737977.
Gauthier ML, Torretto Cheryl, Ly John, Francescutti Valerie, O'Day Danton H (Aug 2003). „Protein kinase Calpha negatively regulates cell spreading and motility in MDA-MB-231 human breast cancer cells downstream of epidermal growth factor receptor”. Biochem. Biophys. Res. Commun.307 (4): 839–46. DOI:10.1016/S0006-291X(03)01273-7. PMID12878187.
Bedrin MS, Abolafia C M, Thompson J F (Jul 1997). „Cytoskeletal association of epidermal growth factor receptor and associated signaling proteins is regulated by cell density in IEC-6 intestinal cells”. J. Cell. Physiol.172 (1): 126–36. DOI:10.1002/(SICI)1097-4652(199707)172:1<126::AID-JCP14>3.0.CO;2-A. PMID9207933.
Sun J, Nanjundan Meera, Pike Linda J, Wiedmer Therese, Sims Peter J (May 2002). „Plasma membrane phospholipid scramblase 1 is enriched in lipid rafts and interacts with the epidermal growth factor receptor”. Biochemistry41 (20): 6338–45. DOI:10.1021/bi025610l. PMID12009895.
Sarmiento M, Puius Y A, Vetter S W, Keng Y F, Wu L, Zhao Y, Lawrence D S, Almo S C, Zhang Z Y (Jul 2000). „Structural basis of plasticity in protein tyrosine phosphatase 1B substrate recognition”. Biochemistry39 (28): 8171–9. DOI:10.1021/bi000319w. PMID10889023.
Zhang ZY, Walsh A B, Wu L, McNamara D J, Dobrusin E M, Miller W T (Mar 1996). „Determinants of substrate recognition in the protein-tyrosine phosphatase, PTP1”. J. Biol. Chem.271 (10): 5386–92. DOI:10.1074/jbc.271.10.5386. PMID8621392.
Tomic S, Greiser U, Lammers R, Kharitonenkov A, Imyanitov E, Ullrich A, Böhmer F D (Sep 1995). „Association of SH2 domain protein tyrosine phosphatases with the epidermal growth factor receptor in human tumor cells. Phosphatidic acid activates receptor dephosphorylation by PTP1C”. J. Biol. Chem.270 (36): 21277–84. DOI:10.1074/jbc.270.36.21277. PMID7673163.
Keilhack H, Tenev T, Nyakatura E, Godovac-Zimmermann J, Nielsen L, Seedorf K, Böhmer F D (Sep 1998). „Phosphotyrosine 1173 mediates binding of the protein-tyrosine phosphatase SHP-1 to the epidermal growth factor receptor and attenuation of receptor signaling”. J. Biol. Chem.273 (38): 24839–46. DOI:10.1074/jbc.273.38.24839. PMID9733788.
Lu Y, Brush J, Stewart T A (Apr 1999). „NSP1 defines a novel family of adaptor proteins linking integrin and tyrosine kinase receptors to the c-Jun N-terminal kinase/stress-activated protein kinase signaling pathway”. J. Biol. Chem.274 (15): 10047–52. DOI:10.1074/jbc.274.15.10047. PMID10187783.
Soubeyran P, Kowanetz Katarzyna, Szymkiewicz Iwona, Langdon Wallace Y, Dikic Ivan (Mar 2002). „Cbl-CIN85-endophilin complex mediates ligand-induced downregulation of EGF receptors”. Nature416 (6877): 183–7. DOI:10.1038/416183a. PMID11894095.
Szymkiewicz I, Kowanetz Katarzyna, Soubeyran Philippe, Dinarina Ana, Lipkowitz Stanley, Dikic Ivan (Oct 2002). „CIN85 participates in Cbl-b-mediated down-regulation of receptor tyrosine kinases”. J. Biol. Chem.277 (42): 39666–72. DOI:10.1074/jbc.M205535200. PMID12177062.
Sakaguchi K, Okabayashi Y, Kido Y, Kimura S, Matsumura Y, Inushima K, Kasuga M (Apr 1998). „Shc phosphotyrosine-binding domain dominantly interacts with epidermal growth factor receptors and mediates Ras activation in intact cells”. Mol. Endocrinol.12 (4): 536–43. DOI:10.1210/me.12.4.536. PMID9544989.
Keely SJ, Calandrella S O, Barrett K E (Apr 2000). „Carbachol-stimulated transactivation of epidermal growth factor receptor and mitogen-activated protein kinase in T(84) cells is mediated by intracellular ca(2+), PYK-2, and p60(src)”. J. Biol. Chem.275 (17): 12619–25. DOI:10.1074/jbc.275.17.12619. PMID10777553.
Sato K, Kimoto M, Kakumoto M, Horiuchi D, Iwasaki T, Tokmakov A A, Fukami Y (Sep 2000). „Adaptor protein Shc undergoes translocation and mediates up-regulation of the tyrosine kinase c-Src in EGF-stimulated A431 cells”. Genes Cells5 (9): 749–64. DOI:10.1046/j.1365-2443.2000.00358.x. PMID10971656.
Xia L, Wang Lijuan, Chung Alicia S, Ivanov Stanimir S, Ling Mike Y, Dragoi Ana M, Platt Adam, Gilmer Tona M, Fu Xin-Yuan, Chin Y Eugene (Aug 2002). „Identification of both positive and negative domains within the epidermal growth factor receptor COOH-terminal region for signal transducer and activator of transcription (STAT) activation”. J. Biol. Chem.277 (34): 30716–23. DOI:10.1074/jbc.M202823200. PMID12070153.
Sehat B, Andersson Sandra, Girnita Leonard, Larsson Olle (Jul 2008). „Identification of c-Cbl as a new ligase for insulin-like growth factor-I receptor with distinct roles from Mdm2 in receptor ubiquitination and endocytosis”. Cancer Res.68 (14): 5669–77. DOI:10.1158/0008-5472.CAN-07-6364. PMID18632619.
Ferguson Km, B. M.; Berger, M. B.; Mendrola, J. M.; Cho, H. S.; Leahy, D. J.; Lemmon, M. A. (2003). „EGF activates its receptor by removing interactions that autoinhibit ectodomain dimerization”. Molecular Cell11 (2): 507–517. DOI:10.1016/S1097-2765(03)00047-9. PMID12620237.edit
Ikeda, K; Nomori, H; Mori, T; Sasaki, J; Kobayashi, T (2008). „Novel germline mutation: EGFR V843I in patient with multiple lung adenocarcinomas and family members with lung cancer”. The Annals of Thoracic Surgery85 (4): 1430-2. DOI:10.1016/j.athoracsur.2007.10.012. PMID18355544.edit